RVNCRevance Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsNov 7
Mkt Cap$381.02M
Vol4.12M
53

Neutral Sentiment

How do you feel about RVNC?

News
all
press releases
News Placeholder
Revance Therapeutics Stock’s Retail Sentiment Muted Even As Teoxane Makes Better Offer Than Crown Labs
The offer represents a 16% premium over the $3.10-per-share agreement with Crown Laboratories announced last month.
Stocktwits
News Placeholder
Revance Therapeutics Stock Plummets To 4-Month Low As Crown Labs Halves Takeover Offer: Retail Fumes
The price cut follows a notice received by Revance in September alleging violations of an exclusive distribution agreement with Teoxane.
Stocktwits
<
...
1
>

Advertisement|Remove ads.